We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+46.47%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$407M
AUM Growth
+$69.8M
Cap. Flow
-$22.2M
Cap. Flow %
-5.45%
Top 10 Hldgs %
24.1%
Holding
129
New
20
Increased
20
Reduced
20
Closed
27

Top Buys

Rank Stock Value
1
VCYT icon
Veracyte
VCYT
+$8.34M
2
TWST icon
Twist Bioscience
TWST
+$6.32M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$5.16M
4
PACB icon
Pacific Biosciences
PACB
+$5.1M
5
TDOC icon
Teladoc Health
TDOC
+$4.41M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$11.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.49M
3
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$6.86M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$5.86M
5
ARWR icon
Arrowhead Research
ARWR
+$5.76M

Sector Composition

Rank Sector Weight
1 Healthcare 45.15%
2 Technology 24.29%
3 Communication Services 9.57%
4 Consumer Discretionary 5.1%
5 Financials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XPEV icon
101
XPeng
XPEV
$12.4B
$857K 0.21%
+20,000
New +$735K
CELL
102
DELISTED
PhenomeX Inc. Common Stock
CELL
$814K 0.2%
+9,100
New +$765K
AAPL icon
103
Apple
AAPL
$4.54T
– –
-12,340
Closed -$1.43M
ADBE icon
104
Adobe
ADBE
$99.5B
– –
-6,171
Closed -$3.03M
CNS icon
105
Cohen & Steers
CNS
$4.23B
– –
-2,400
Closed -$134K
CPRX
106
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-203,133
Closed -$603K
CRSP icon
107
CRISPR Therapeutics
CRSP
$4.73B
– –
-70,000
Closed -$5.86M
CTAS icon
108
Cintas
CTAS
$81.9B
– –
-34,156
Closed -$2.84M
FDX icon
109
FedEx
FDX
$72.7B
– –
-19,569
Closed -$4.92M
GDOT icon
110
Green Dot
GDOT
$743M
– –
-46,843
Closed -$2.37M
GEO icon
111
The GEO Group
GEO
$4.13B
– –
-156,274
Closed -$1.77M
INTU icon
112
Intuit
INTU
$86.5B
– –
-6,359
Closed -$2.07M
LVS icon
113
Las Vegas Sands
LVS
$31.7B
– –
-24,929
Closed -$1.16M
MDB icon
114
MongoDB
MDB
$27.1B
– –
-13,042
Closed -$3.02M
NRC icon
115
NRC Health Common Stock
NRC
$432M
– –
-13,917
Closed -$685K
OSPN icon
116
OneSpan
OSPN
$574M
– –
-98,200
Closed -$2.06M
PAYC icon
117
Paycom
PAYC
$7.64B
– –
-9,630
Closed -$3M
PLMR icon
118
Palomar
PLMR
$3.55B
– –
-27,000
Closed -$2.81M
SSTK icon
119
Shutterstock
SSTK
$198M
– –
-44,980
Closed -$2.34M
SUPN icon
120
Supernus Pharmaceuticals
SUPN
$2.59B
– –
-83,632
Closed -$1.74M
TREE icon
121
LendingTree
TREE
$447M
– –
-9,486
Closed -$2.91M
TTEC icon
122
TTEC Holdings
TTEC
$121M
– –
-10,700
Closed -$584K
WDAY icon
123
Workday
WDAY
$39.6B
– –
-14,500
Closed -$3.12M
WT icon
124
WisdomTree
WT
$2.96B
– –
-325,644
Closed -$1.04M
CPAY icon
125
Corpay
CPAY
$25B
– –
-9,660
Closed -$2.3M
2 3 4
5
6

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Capital Impact Advisors held 129 positions worth $407M, up 21% from $337M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Capital Impact Advisors withdrew a net $22.2M in Q4 2020, closing 27 positions and reducing 20 holdings. Its most notable exit was Livongo Health, Inc. Common Stock, an estimated $6.86M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 31% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Capital Impact Advisors opened a new position in Veracyte worth $8.81M.

  • Capital Impact Advisors's largest Q4 2020 buy was Veracyte: 180,000 shares worth $8.81M.
  • Capital Impact Advisors added most to Twist Bioscience in Q4 2020, an estimated $6.32M increase.
  • Capital Impact Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $11.4M.
  • Capital Impact Advisors fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $6.86M.
  • Capital Impact Advisors's ten largest holdings make up 24% of its $407M portfolio in Q4 2020.
  • Capital Impact Advisors opened 20 new positions and closed 27 in Q4 2020.
  • Capital Impact Advisors's portfolio value rose 21% quarter-over-quarter to $407M.

Based on Capital Impact Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.